Particular areas of expertise: Licensing, Marketing, Corporate Strategy, Portfolio Strategy, Valuation, Competitive Intelligence, Technology Assessment, Corporate Financing, Pharmaceutical Development, Drug Delivery
Valeo Partners is a Washington DC-based strategy consultancy, focuses on providing strategic solutions to industry and government organizations operating in the pharmaceutical, drug delivery and biodefense markets. Their partners have over 25 years of combined consulting experience helping leading industry & government organizations achieve results. Valeo Partners has an unmatched business network in the US life science business, e.g. in order to place your product in the US with the right distribution partner.
Debra Bingham is a Partner at Valeo Partners, a Washington DC-based consulting firm that specializes in business development strategy and business process optimization. Prior to joining Valeo Partners, Ms. Bingham was a Vice President at a technology strategy firm with over a decade of experience working with technology assessment, drug delivery, and product development for pharmaceutical, specialty pharmaceutical and chemical companies. She managed all aspects of a multi-million dollar practice specializing in business development, industry monitoring, in-depth market reviews, and strategic market assessment. She has specialized experience in strategic planning, competitive intelligence, and technology scouting and is an active member of Licensing Executives Society (LES), American Association for Pharmaceutical Scientists (AAPS), and Controlled Release Society (CRS). She holds a BS in biology with graduate research in immunology and molecular genetics.
